India and Brazil on Saturday signed a India-Brazil MoU to strengthen cooperation in regulating pharmaceutical and medical products, marking a key move to deepen health sector ties. The agreement was formalized at Hyderabad House between Central...
Indian pharmaceutical company Lupin Limited has expanded its presence in the U.S. healthcare market with the launch of a diabetes medication after receiving approval from the United States Food and Drug Administration.
Supriya Lifescience Limited has received a major regulatory boost as the U.S. Food and Drug Administration issued an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) classification for its API manufacturing unit in...
Bharat Parenterals Ltd said its subsidiary, Innoxel Lifesciences, has received five observations from the United States Food and Drug Administration (USFDA) following a recent USFDA inspection at its Vadodara facility.
India is steadily emerging as a global leader in using artificial intelligence in healthcare, thanks to its strong digital growth, increasing health awareness, and rising investments in health technology. As AI becomes a part of everyda...
Merck has secured a key step forward as the Merck KEYTRUDA FDA priority review gains momentum in bladder cancer treatment. The US Food and Drug Administration has granted priority review for KEYTRUDA and KEYTRUDA QLEX, both evaluated in...
India’s ammonia rule is tightening the availability of a key raw material for pharmaceutical companies, after the government directed that surplus ammonia from urea plants be reserved primarily for fertilizer production.
India is set to take a major step toward improving end-of-life support as the Indian Council of Medical Research rolls out a palliative care study across multiple states. Announced today, this initiative aims to address a long-standing gap in the...
India’s CDSCO prior intimation mechanism is now live, marking a shift in how drug makers begin early-stage manufacturing for research. The Central Drugs Standard Control Organisation has rolled out the system from April 21, 2026, replacing the...
NCR’s fake Mounjaro problem is growing fast—and most people don’t see it coming. In fact, it is no longer limited to shady corners of the market. It’s now tied to a Rs 70 lakh cache of counterfeit injections recently uncovered, pointing to...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")